Description
Here are the main uses of Bisoprolol 10mg (Concor) tablets:
- Hypertension (High Blood Pressure)
- Coronary Artery Disease
- Heart Failure
- Certain Arrhythmias
- After a Heart Attack (Myocardial Infarction)
Sh22,500.00
Bisoprolol, sold under the brand name “Concor” among others, is a medication belonging to the class of beta-blockers. It is commonly prescribed for various cardiovascular conditions.
Here are the main uses of Bisoprolol 10mg (Concor) tablets:
Settings | BISOPROLOL 10MG CONCOR 30S remove | Artemether Syrup 60ml ARH-L remove | OFLOX OZ 200\500 MG remove | Ampiclox Capsules remove | ACNOTIN 10MG remove | AMBROSAN SYRUP AMBROXOL 100ML remove |
---|---|---|---|---|---|---|
Image | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
SKU | ||||||
Rating | ||||||
Price | Sh22,500.00 | Sh4,000.00 | Sh7,000.00 | Sh10,000.00 | Sh38,000.00 | Sh3,000.00 |
Stock | ||||||
Availability | ||||||
Add to cart | ||||||
Description | Bisoprolol, sold under the brand name "Concor" among others, is a medication belonging to the class of beta-blockers. It is commonly prescribed for various cardiovascular conditions. | Treats bacterial infections of the:
| ||||
Content | Here are the main uses of Bisoprolol 10mg (Concor) tablets:
| Artemether(Coartem) generic Artemether is a potent and quick-acting antimalarial agent, used for treating chloroquine-resistant falciparum malaria, including cerebral malaria. | Used to treat:
| AMPICLOX CAPSULE contains two antibiotics, namely: Ampicillin and Cloxacillin. AMPICLOX CAPSULE works by preventing the formation of bacterial cell covering, which is necessary for their survival. Thereby kills the bacteria and helps in treating and preventing bacterial infections | Isotretinoin Capsule belongs to a group of medicines called retinoids, which are closely related to vitamin A derivative. It is used to treat:
| Prescribed for various respiratory diseases such as
|
Weight | ||||||
Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
Additional information |
Reviews
There are no reviews yet.